Pharma Industry Leaders Lambast IP Waivers & Weigh In on Vaccine Inequity
At the recent Global Biopharma press briefing on COVID-19, held by the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA), industry leaders took on the issue of vaccine inequity, challenging…